[Plasmapheresis: First clinical results in malignant tumors].
32 patients (10 females and 22 males) with chemotherapy-resistant tumors were again treated with the previously ineffective chemotherapy after plasmapheresis. 19 of 32 patients showed a minor response or no change lasting more than 3 1/2 weeks; in 10 of the 32 patients it lasted for more than 8 weeks.
D003110:Colonic Neoplasms / Q000628:therapy; D004351:Drug Resistance; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000628:therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D010956:Plasmapheresis / Q000379:methods*; D012004:Rectal Neoplasms / Q000628:therapy; D012709:Serum Albumin / Q000627:therapeutic use
D012709:Serum Albumin
Plasmapherese: erste klinische Ergebnisse bei malignen Tumoren.